T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
View the Complete Portfolio of Investments
Asset Allocation
as of 03/31/2013
Domestic Stock 60.9%
Domestic Bond 20.0%
Cash 13.6%
Foreign Bonds 3.5%
Convertibles 1.9%
Foreign Stock 0.4%
Preferreds 0.4%
Options -0.4%
Volatility and Other Measures
as of 04/30/2013
Beta 0.71
R² 0.97
Standard Deviation 10.61
Price/Earnings Ratio (Domestic) 15.0
Earnings Growth Rate (Domestic) 11.6
Turnover Rate 71.8
Median Market
Capitalization 		$28,960.96 Million
10 Largest Holdings
Quarter-End Top Holdings with Weightings
Represents 27.10 % of Total Net Assets
View Holdings as of:
Danaher
FANNIE MAE REMICS
Fiserv
Invesco
Pfizer
State Street
Texas Instruments
Thermo Fisher Scientific
US Bancorp/MN
United Technologies
As of 03/31/2013 the Capital Appreciation Fund had a total of 257 holdings.
Sector Diversification
as of 04/30/2013
% of Total Net Assets
Financials 11.5%
Information Technology 11.2%
Consumer Discretionary 9.6%
Industrials & Business Services 9.0%
Health Care 8.2%
Consumer Staples 7.3%
Energy 3.5%
Utilities 2.9%
Materials 0.5%
Telecommunication Services 0.1%
See Glossary for additional details on all data elements.
From MONEY® Magazine, January/February 2013 ©2013 Time Inc. MONEY and MONEY 70 are registered trademarks of Time Inc. and are used under license. MONEY and Time Inc. are not affiliated with, and do not endorse products or services of, T. Rowe Price.